本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CytoMed Therapeutics Limited

2.21
-0.0400-1.78%
成交量:7,945.00
成交额:1.79万
市值:2,550.34万
市盈率:-11.29
高:2.37
开:2.37
低:2.21
收:2.25
数据加载中...
2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/23

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/22

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/19

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/24

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/04/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/03/31

SEC问询函

Form CORRESP - Correspondence
2023/03/31

SEC问询函

Form CORRESP - Correspondence
2023/03/31

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/03/31

SEC问询函

Form CORRESP - Correspondence
2023/03/30

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/03/30

SEC问询函

Form CORRESP - Correspondence
2023/03/28

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]